HIGHLIGHTS
- who: Aliza Naz et al. from the National Center for Bioinformatics, Quaid-i-Azam University, POBox, Riyadh, Saudi Arabia have published the research: Repurposing FIASMAs against Acid Sphingomyelinase for COVID-19: A Computational Molecular Docking and Dynamic Simulation Approach, in the Journal: Molecules 2023, 28, x FOR PEER REVIEW for the Complex 1 over the simulation run of 100 ns. of /2023/
- what: The aim of this study was to identify potential inhibitors acid sphingomyelinase (ASM) to prevent coronavirus infection. This study was aimed towards achieving the aforementioned goal. RMSF analysis was conducted to explore . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.